[Toxic neurologic manifestations during angina pectoris treatment (perhexiline maleate and amiotadone hydrochloride)].
D000638:Amiodarone / Q000009:adverse effects*; D000787:Angina Pectoris / Q000188:drug therapy; D001572:Benzofurans / Q000009:adverse effects*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D004576:Electromyography; D006801:Humans; D002479:Inclusion Bodies / Q000648:ultrastructure; D050356:Lipid Metabolism; D008854:Microscopy, Electron; D009069:Movement Disorders / Q000139:chemically induced; D009132:Muscles / Q000473:pathology; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology; D010292:Paresthesia / Q000139:chemically induced; D010480:Perhexiline / Q000009:adverse effects*; D010525:Peripheral Nerves / Q000473:pathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D010860:Pigments, Biological / Q000378:metabolism; D010880:Piperidines / Q000009:adverse effects*; D011129:Polyradiculoneuropathy / Q000139:chemically induced; D012583:Schwann Cells / Q000648:ultrastructure; D012867:Skin / Q000473:pathology; D014202:Tremor / Q000139:chemically induced
D001572:Benzofurans; D002556:Cerebrospinal Fluid Proteins; D010860:Pigments, Biological; D010880:Piperidines; D010480:Perhexiline; D000638:Amiodarone
Manifestation neurologiques toxiques au cours des traitements antiangoreux. (Maleate de perhexiline et chlorhydrate d'amiotadone).